home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> mail archive   |   Search register for news alert (free)  
  FS Zollmann: HUM-MOLGEN News Alert - August 03, 2006  
   

archive of HUM-MOLGEN mails

 
 

[Author Prev][Author Next][Thread Prev][Thread Next][Author Index][Topic Index]

To: list@hum-molgen.de
Subject: HUM-MOLGEN News Alert - August 03, 2006
From: FS Zollmann <zollmann@hum-molgen.de>
Date: Thu, 03 Aug 2006 13:58:39 +0200

__________________________________________________________________________

   CHI's Fourth Annual
   Discovery on Target: Target Discovery & Target Validation Strategies
   October 23-26, 2006 | World Trade Center | Boston, MA

   => http://hum-molgen.org/promotion-DoT

   Designed to expand the coverage of science and business strategies,
   this event will focus on disease target identification and effectiveness
__________________________________________________________________________


INTERNATIONAL COMMUNICATION FORUM IN HUMAN MOLECULAR GENETICS
HUM-MOLGEN News Alert - August 03, 2006 - http://hum-molgen.org


Genetic News
by T.M. D'Souza, S. Chandler, T. Dalaya, K. Markey, J. Mill, La Merie S.L,
R. Nemade, D. Sharma, F.S. Zollmann
http://hum-molgen.org/NewsGen

- Promising Therapy For ALS Delivers Antisense Drug Directly To Nervous
   System
    Delivering agents across the blood-brain barrier likely to be
    effective treatment for other neurodegenerative diseases
    http://hum-molgen.org/NewsGen/08-2006/msg12.html

- Cheap fast way to crack genome code
    US and Australian scientists have pioneered a new hybrid method for
    genomic sequencing that is faster and cheaper than state of the art
    technologies.
    http://hum-molgen.org/NewsGen/08-2006/msg11.html

- Neutralizing HIV
    Study reveals the interaction between a human antibody and a protein
    found on the surface of the HIV-1 virus.
    http://hum-molgen.org/NewsGen/08-2006/msg10.html

- Gleevec May Cause Heart Problems
    Imatinib mesylate (Gleevec), a drug used to treat chronic myelogenous
    leukemia (CML), can kill heart cells.
    http://hum-molgen.org/NewsGen/08-2006/msg09.html

- Inhibiting Inflammation In Multiple Sclerosis
    T cells, a type of immune cell, can impede the development and
    progression of multiple sclerosis in mice.
    http://hum-molgen.org/NewsGen/08-2006/msg08.html

- Mouse Model Suggests Treatment Strategy For Muscular Dystrophy
    Study reports a reversible mouse model of myotonic dystrophy, the
    most common form of muscular dystrophy in adults.
    http://hum-molgen.org/NewsGen/08-2006/msg07.html

- Receptors In The Mouse Nose May Be Pheromone Detectors
    Biologists have discovered a second set of olfactory receptors in the
    mouse nose, including ones that may detect pheromones and might
    therefore aid in the mating game.
    http://hum-molgen.org/NewsGen/08-2006/msg06.html

- Choosing Face
    Study clarifies the role of particular neurons in a region of
    monkeys' brains known to be important for object recognition.
    http://hum-molgen.org/NewsGen/08-2006/msg05.html

- Active Sites Of A Hepatitis C Virus Enzyme Revealed
    The crystal structure of one of the hepatitis C viral proteins could
    offer new opportunities for antiviral drug design.
    http://hum-molgen.org/NewsGen/08-2006/msg04.html

- Unexpected Inheritance
    Research supports the idea that RNA partly determines the inherited
    characteristics of plants and animals.
    http://hum-molgen.org/NewsGen/08-2006/msg03.html

- Melanoma Risk Linked to the Gene for the Melanocortin-1 Receptor and
   Sun Exposure
    MC1R gene variants are correlated with BRAF mutations and the risk of
    melanoma with intermittent exposure to sunlight.
    http://hum-molgen.org/NewsGen/08-2006/msg02.html

- A Full Pipeline of Follow-on TNF-Antagonists
    The US$ 7.6 bln market of TNF-antagonists attracts numerous follow-on
    compounds including improved TNF-antagonists and molecules
    originating from new technologies
    http://hum-molgen.org/NewsGen/08-2006/msg01.html

- New Genomes to be Targeted for Sequencing
    United States' National Human Genome Research Institute Large Scale
    Sequencing Research Network adds more animal genomes to it's To Do
    List.
    http://hum-molgen.org/NewsGen/07-2006/msg32.html

- New Blood Test for the Prediction and Complications of Sickle Cell
   Disease
    Brain natriuretic peptide or BNP is a hormone whose levels might also
    correlate with the severity of pulmonary hypertension and risk of
    death in sickle cell patients.
    http://hum-molgen.org/NewsGen/07-2006/msg31.html

- Contact Genetic News editors
    WWW: http://hum-molgen.org/editors.html
    E-mail: news@hum-molgen.org


DIAGnostics - Clinical Research (professional requests)
http://hum-molgen.org/clinical-research/

- Post diagnostic request / call for collaboration
    http://hum-molgen.org/diagnostic-posting or
    contact admin@hum-molgen.org


Biotechnical requests and sources
http://hum-molgen.org/biotechnology

- Post request or source
   http://hum-molgen.org/biotechnical-request-posting


Biomedical Positions
http://hum-molgen.org/positions/

- Cancer Research: POST-DOCTORAL FELLOW
    INSERM EMI229, Montpellier, 34298 Cedex 5, France
    http://hum-molgen.org/positions/postdocs/2622.html

- Cell and Molecular Biology / Anatomy: PhD studentship and Postdoctoral
   Position
    Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona,
    Spain
    http://hum-molgen.org/positions/postdocs/2624.html

- Genetics: Scientist  - Genotyping
    Idenix Pharmaceuticals, Cambridge, MA, USA
    http://hum-molgen.org/positions/postdocs/2621.html

- Genetics: Post Doctoral Fellow
    Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    http://hum-molgen.org/positions/postdocs/2623.html

- Write a position announcement
    http://hum-molgen.org/flyer/positions.pdf
    1) Set up account: http://hum-molgen.de/cgi-bin/positions.pl?register
    2) Post position(s): http://hum-molgen.de/cgi-bin/positions.pl?login


Literature
http://hum-molgen.org/literature/


Events in bioscience and medicine
http://hum-molgen.org/meetings/

- Post event (free)
   http://hum-molgen.de/cgi-bin/meetings.pl?login


Registry of Biomedical Companies (1229 active entries)
http://hum-molgen.org/companies/


Mailing List Administration (Join or leave the list)
http://hum-molgen.org/subscribe-na/


Feedback
contact admin@hum-molgen.org


Advertise at HUM-MOLGEN
http://hum-molgen.org/flyer/advertise.pdf
contact FS Zollmann (dialogue@hum-molgen.org)

__________________________________________________________________________

   CHI's Fourth Annual
   Discovery on Target: Target Discovery & Target Validation Strategies
   October 23-26, 2006 | World Trade Center | Boston, MA

   => http://hum-molgen.org/promotion-DoT

   Designed to expand the coverage of science and business strategies,
   this event will focus on disease target identification and effectiveness.
   Discovery on Target  will continue its tradition of offering the highest
   caliber scientific content with increased time for networking and
   discussion. The Executive Track will concentrate on the heart of current
   strategic business issues important to target discovery.

   Discovery on Target 2006 offers:
   Inaugural Ion Channels
   Second Annual Preclinical Disease Models
   Fourth Annual RNAi
   Second Annual Executive on Target
   Sixth Annual Chemogenomics

   PLUS!
   Pre-Conference Short Courses
   Second Annual Regulomics Symposium
__________________________________________________________________________ 





   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Mail converted by MHonArc 2.4.4
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2005 HUM-MOLGEN. All rights reserved. Liability and Copyright.